Aspira Pathlab & Diagnostics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024
For the full year, the company reported sales was INR 132.05 million compared to INR 144.57 million a year ago. Revenue was INR 136.26 million compared to INR 147.78 million a year ago. Net loss was INR 26.72 million compared to INR 0.887 million a year ago. Basic loss per share from continuing operations was INR 2.6 compared to INR 0.09 a year ago. Diluted loss per share from continuing operations was INR 2.6 compared to INR 0.09 a year ago.